Global Predictive Genetic Counselling Market, By Setting Type (DTC, Professional), Predictive Testing (Genetic Susceptibility Test, Predictive Diagnostics, Population Screening) Application (Consumer Genomics, Breast and Ovarian Cancer, Cardiovascular Screening, Diabetic Screening and Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/ Prostate Cancer Screening, Orthopedic and Musculoskeletal, Others) – Industry Trends and Forecast to 2029
Predictive Genetic Counselling Market Analysis and Size
Predictive genetic testing is a new expanding sector in public health practises, particularly in economically stable countries. It's being utilised increasingly to drive dietary choices and disease training outcomes. It is usually done in healthy people and includes detecting specific genetic features that may cause disease later in life. Genetic susceptibility testing, predictive diagnostic testing, and population screening are some of the most popular forms of predictive genetic testing.
Data Bridge Market Research analyses that the predictive genetic counselling market which was USD 5.15 billion in 2021, would rocket up to USD 14.28 billion by 2029, and is expected to undergo a CAGR of 13.6 % during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Predictive Genetic Counselling Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Setting Type (DTC, Professional), Predictive Testing(Genetic Susceptibility Test, Predictive Diagnostics, Population Screening) Application (Consumer Genomics, Breast and Ovarian Cancer, Cardiovascular Screening, Diabetic Screening and Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/ Prostate Cancer Screening, Orthopedic and Musculoskeletal, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), BGI Group (China), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), Myriad Genetics, Inc. (U.S.), Pathway (U.S.), Siemens (Germany), Genomic Health, Inc. (U.S.), Admera Health (U.S.), deCODE genetics (Iceland)
|
|
Market Opportunities
|
|
Market Definition
In order to better treatment and support, predictive genetic testing assists in the examination of a genetic state. Additionally, government funding of R&D initiatives to increase genomics accessibility through technical advancements would foster market expansion. Healthier lifestyles and expanding healthcare awareness campaigns have created demand in this sector.
Predictive Genetic Counselling Market Dynamics
Drivers
- Rising wellness care awareness
The market for predictive genetics counselling is expected to grow between 2022 and 2029 as a result of rising wellness care awareness and a demographic trend toward leading a healthy lifestyle.
- Government Initiatives
Predictive genetics counselling is expected to grow throughout the forecast period due to factors including the government's and other administrative organisations' upcoming consideration of state health care, improved effectiveness and quality standards of genetic measurement, and the prevalence of chronic disorders and hereditary illnesses like Parkinson's disease and cystic fibrosis.
- Research and development activities
Predictive genetic testing aids in the investigation of a genetic state in order to better treat and support patients. Additionally, government support for R&D projects aimed at improving technical accessibility of genomics would promote market growth.
Opportunities
The overall market share is also increasing as a result of the growing desire to understand one's family history. The excessive frequency of collaboration ideas among services providers in the genomics industry, which has led to a wider frontier of predictive genetic testing, is one of the main growth factors.
Restraints/Challenges
The market's growth through the forecast period of 2022 to 2029 may be constrained by stringent administrative practises and regulations for the endorsement of genetic studies.
This predictive genetic counselling market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the predictive genetic counselling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Predictive Genetic Counselling Market
There is little doubt that the global COVID-19 pandemic epidemic has affected a number of global sectors and caused economic disruptions. As a result of the disease's emergence and the resulting increase in demand for medical care, the healthcare industry has been greatly expanded. The current COVID pandemic has not impacted genetic counselling since it is a completely distinct healthcare area focusing mostly on oncology. In its own right, cancer is an emergency condition that has been progressing at its own rate. As a result, the novel coronavirus's spread has little impact on the global market for predictive genetic counselling.
Global Predictive Genetic Counselling Market Scope
The predictive genetic counselling market is segmented on the basis of setting type, predictive testing, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Setting Type
- DTC
- Professional
Predictive Testing
- Genetic Susceptibility Test
- Predictive Diagnostics
- Population Screening
Application
- Consumer Genomics
- Breast and Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening and Monitoring
- Colon Cancer
- Parkinsonism/Alzheimer’s Disease
- Urologic Screening/Prostate Cancer Screening
- Orthopedic and Musculoskeletal
- Others
Predictive Genetic Counselling Market Regional Analysis/Insights
The predictive genetic counselling market is analysed and market size insights and trends are provided by country, setting type, predictive testing, and application as referenced above.
The countries covered in the predictive genetic counselling market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market owing to the occupancy of numerous professionals based in the United States.
Asia-Pacific (APAC) is predicted to grow with the fastest CAGR due to rush in disposable earnings as well as healthcare expenditures.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Predictive Genetic Counselling Market Share Analysis
The predictive genetic counselling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to predictive genetic counselling market.
Some of the major players operating in the predictive genetic counselling market are:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- BGI Group (China)
- Bio-Rad Laboratories, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- QIAGEN (Germany)
- Myriad Genetics, Inc. (U.S.)
- Pathway (U.S.)
- Siemens (Germany)
- Genomic Health, Inc. (U.S.)
- Admera Health (U.S.)
- deCODE genetics (Iceland)
SKU-